Introduction
In 1988, the KNCV Section Farmacochemie established a biannual award to be granted to the most outstanding doctoral dissertation in medicinal chemistry by a PhD student at a Dutch university. The first five prizes, the so-called MFR Medicinal Chemistry Prizes, were sponsored by Medisch Farmaceutische Research (MFR), a Dutch foundation that was part of Nefarma. In 1998, sponsorship was taken over by Stichting Farmacochemische Congressen. The prize was sponsored by Mercachem (2010-2017) and MercachemSyncom (2018-2020), and since 2020 is sponsored by Symeres. As of 2020, the Section Farmacochemie broadened her scope by changing her name to KNCV Medicinal Chemistry & Chemical Biology (MCCB). Accordingly, the biannual award is granted to the best doctoral dissertation in medicinal chemistry or chemical biology by a PhD student at a Dutch university.
Call for nominations 2021-2022
At the Spring Symposium of 2023, the KNCV Division Medicinal Chemistry & Chemical Biology (MCCB) will present the winner of the biannual KNCV Medicinal Chemistry & Chemical Biology Dutch PhD thesis prize. The prize - consisting of a certificate, a work of art, and a € 1000 cash prize sponsored by Symeres – will be awarded for the best doctoral dissertation in medicinal chemistry or chemical biology at a Dutch university, defended during the years 2021 and 2022. Nominations should be submitted by sending the thesis (pdf allowed but 5 hardcopies preferred) and a recommendation letter to the secretary of the division before January 6, 2023. Only one candidate per promotor can be nominated.
An assessment committee consisting of a chairman (board member of the Division) and at least two external scientists will judge the nominations. The winner will present the winning work as representative of The Netherlands at the EFMC Young Medicinal Chemist Symposium (EFMC-YMCS) September 7-8, 2023.
On behalf of the KNCV-MCCB board,
Rutger Folmer (Secretary)
Symeres (Mercachem)
Kerkenbos 1013
6546 BB Nijmegen
rutger.folmer@symeres.com
